In Nigeria, DNA testing is rapidly evolving beyond its traditional roles in legal battles and family disagreements. DemyHealth Clinic and Genomic Medicine have recently integrated cutting-edge sequencing technologies, expanding the scope of DNA analysis to serve justice, healthcare, and scientific research more comprehensively.
The facility has equipped itself with the ABI 3500Dx Genetic Analyzer alongside the Illumina Next-Generation Sequencing (NGS) system, positioning it among a select group of African laboratories capable of conducting high-throughput genetic examinations.
Mr. Casmir Ali, Head of Molecular Diagnostics at DemyHealth, highlighted the increasing significance of DNA testing in supporting law enforcement, particularly in combating child trafficking.
“DNA analysis is now a critical tool in saving lives. We help authorities confirm or refute alleged parental links, especially in cases involving suspected child trafficking,” he explained.
He further emphasized that DNA profiling plays a vital role in addressing sensitive issues such as incest investigations, immigration conflicts, and undisclosed familial relationships.
Dr. Emeka Obiodunukwe, Chairman and CEO of DemyHealth, shared that the laboratory has been instrumental in identifying victims of tragic events like aviation disasters and structural collapses.
“The relief families experience when a loved one’s remains are accurately identified is immeasurable. DNA testing offers legal clarity and cultural closure, enabling proper funeral rites,” he remarked.
Additionally, Dr. Obiodunukwe noted that DNA technology assists in resolving cases involving long-lost individuals and correcting misidentifications in morgues.
The recent increase in migration has also driven up the demand for DNA testing services. As more Nigerians seek visas and citizenship abroad, embassies require authenticated biological evidence for family reunification purposes. DemyHealth is meeting this demand by providing legally admissible DNA test results.
Beyond forensic and legal applications, the newly acquired sequencing platforms are propelling advancements in molecular medicine. Dr. Sharon Akinpelu, Senior Molecular Scientist at DemyHealth, explained that DNA testing is now integral to cancer diagnosis, rare genetic disorder detection, and monitoring infectious diseases.
“Each genetic sample brings us closer to developing treatments tailored specifically for African populations, who have historically been underrepresented in global medical research,” she stated.
Clinical uses have expanded to include newborn screening and carrier testing for diseases like sickle cell anemia, HLA typing to facilitate organ transplants, and pharmacogenomics to optimize drug safety and efficacy.
The organization is also venturing into ancestry testing, enabling Nigerians to explore their genetic heritage, as well as livestock DNA analysis to enhance breeding programs and bolster food security.
With these enhanced capabilities, DNA testing in Nigeria is transforming from a tool primarily for resolving paternity issues into a multifaceted resource that strengthens the justice system, elevates healthcare standards, and drives scientific innovation.
